Cargando…

Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials

BACKGROUND: There has not been conclusive evidence for prevention of brain atrophy by anti-dementia drugs in mild cognitive impairment and Alzheimer’s Disease. METHODS: Relevant studies were identified through searches of PubMed, databases of the Cochrane Library, and PsycINFO citations up to 16 May...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kishi, Taro, Matsunaga, Shinji, Oya, Kazuto, Ikuta, Toshikazu, Iwata, Nakao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675981/ https://www.ncbi.nlm.nih.gov/pubmed/26091818 http://dx.doi.org/10.1093/ijnp/pyv070

Ejemplares similares

Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis
por: Kishi, Taro, et al.
Publicado: (2018)

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
por: Kishi, Taro, et al.
Publicado: (2017)

Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi, Taro, et al.
Publicado: (2018)

Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Okuyama, Yuji, et al.
Publicado: (2016)

Memantine for the treatment of frontotemporal dementia: a meta-analysis
por: Kishi, Taro, et al.
Publicado: (2015)

Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
por: Kishi, Taro, et al.
Publicado: (2015)

Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Matsunaga, Shinji, et al.
Publicado: (2015)

The effects of memantine on behavioral disturbances in patients with Alzheimer’s disease: a meta-analysis
por: Kishi, Taro, et al.
Publicado: (2017)

PT592. Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-analysis
por: Matsunaga, Shinji, et al.
Publicado: (2016)

Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Matsunaga, Shinji, et al.
Publicado: (2015)

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Oya, Kazuto, et al.
Publicado: (2015)

Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials
por: Kishi, Taro, et al.
Publicado: (2016)

Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses
por: Kishi, Taro, et al.
Publicado: (2018)

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
por: Kishi, Taro, et al.
Publicado: (2019)

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis
por: Matsunaga, Shinji, et al.
Publicado: (2015)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi, Taro, et al.
Publicado: (2014)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
por: Kishi, Taro, et al.
Publicado: (2015)

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
por: Kishi, Taro, et al.
Publicado: (2019)

Predicting progression from mild cognitive impairment to Alzheimer's disease using longitudinal callosal atrophy
por: Lee, Sang Han, et al.
Publicado: (2016)

Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials
por: Kishi, Taro, et al.
Publicado: (2020)

Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis
por: Kishi, Taro, et al.
Publicado: (2022)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
por: Kishi, Taro, et al.
Publicado: (2018)

Entorhinal and transentorhinal atrophy in mild cognitive impairment using longitudinal diffeomorphometry
por: Tward, Daniel J., et al.
Publicado: (2017)

Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials
por: Kishi, Taro, et al.
Publicado: (2021)

Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease
por: Ouma, Shinji, et al.
Publicado: (2018)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
por: ten Kate, Mara, et al.
Publicado: (2017)

Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
por: Marino, Silvia, et al.
Publicado: (2019)

P300 and Neuropsychological Assessment in Mild Cognitive Impairment and Alzheimer Dementia
por: Parra, Mario A., et al.
Publicado: (2012)

Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Type Dementia
por: Bulut, Mehmet, et al.
Publicado: (2016)

Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment
por: Christensen, Kurt D., et al.
Publicado: (2020)

Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease
por: Hamilton, Calum A., et al.
Publicado: (2021)

PT568. Depressive Symptoms and Progressive Hippocampal Volume Atrophy Accelerates the Conversion Process to Dementia from Mild Cognitive Impairment
por: Chung, Jun Ku, et al.
Publicado: (2016)

Cognitive Profiles of Patients with Mild Cognitive Impairment or Dementia in Alzheimer's or Parkinson's Disease
por: Hildebrandt, Helmut, et al.
Publicado: (2013)

Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer’s Disease and Mild Cognitive Impairment
por: Hsu, Jung-Lung, et al.
Publicado: (2015)

A multicentre longitudinal study of flortaucipir ((18)F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia
por: Pontecorvo, Michael J, et al.
Publicado: (2019)

Specific EEG Changes Associated with Atrophy of Hippocampus in Subjects with Mild Cognitive Impairment and Alzheimer's Disease
por: Moretti, D. V., et al.
Publicado: (2012)

Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia()
por: La Joie, Renaud, et al.
Publicado: (2013)

Perception of emotions in mild cognitive impairment and Alzheimer’s dementia: does intensity matter?
por: Elferink, Maaike Waanders-Oude, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e2s3jj1rb9binf4kgnj70710dt